{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:04:43Z","timestamp":1793689483051,"version":"4.5.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11195-7","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:07:14Z","timestamp":1762351634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gut microbiota and inflammatory bowel disease: mechanisms, clinical implications, and future directions"],"prefix":"10.1007","volume":"53","author":[{"given":"Sumanpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-4090","authenticated-orcid":false,"given":"Raman","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"10401","key":"11195_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L (2023) Ulcerative colitis. Lancet 402(10401):571\u2013584. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2","journal-title":"Lancet"},{"issue":"8","key":"11195_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","volume":"23","author":"ID Iliev","year":"2025","unstructured":"Iliev ID, Ananthakrishnan AN, Guo C-J (2025) Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat Rev Microbiol 23(8):509\u2013524. https:\/\/doi.org\/10.1038\/s41579-025-01163-0","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"11195_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14050507","volume":"14","author":"D Gyriki","year":"2024","unstructured":"Gyriki D, Nikolaidis C, Stavropoulou E, Bezirtzoglou I, Tsigalou C, Vradelis S et al (2024) Exploring the gut microbiome\u2019s role in inflammatory bowel disease: insights and interventions. J Pers Med 14(5):507. https:\/\/doi.org\/10.3390\/jpm14050507","journal-title":"J Pers Med"},{"issue":"1","key":"11195_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000525925","volume":"104","author":"A Andoh","year":"2023","unstructured":"Andoh A, Nishida A (2023) Alteration of the gut microbiome in inflammatory bowel disease. Digestion 104(1):16\u201323. https:\/\/doi.org\/10.1159\/000525925","journal-title":"Digestion"},{"key":"11195_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1174832","volume":"14","author":"RH Dahal","year":"2023","unstructured":"Dahal RH, Kim S, Kim YK, Kim ES, Kim J (2023) Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. Front Microbiol 14:1174832. https:\/\/doi.org\/10.3389\/fmicb.2023.1174832","journal-title":"Front Microbiol"},{"issue":"4","key":"11195_CR6","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1053\/j.gastro.2023.03.168","volume":"164","author":"E Conder","year":"2023","unstructured":"Conder E, Shay HC, Vekaria H, Erinkitola I, Bhogoju S, Goretsky T et al (2023) Butyrate-induced mitochondrial function improves barrier function in inflammatory bowel disease (IBD). Gastroenterology 164(4):S91. https:\/\/doi.org\/10.1053\/j.gastro.2023.03.168","journal-title":"Gastroenterology"},{"key":"11195_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081807","author":"E Bretto","year":"2025","unstructured":"Bretto E, Urp\u00ec-Ferreruela M, Casanova GR, Gonz\u00e1lez-Su\u00e1rez B (2025) The role of gut microbiota in gastrointestinal immune homeostasis and inflammation: implications for inflammatory bowel disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13081807","journal-title":"Biomedicines"},{"key":"11195_CR8","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.249227","author":"N Gammoh","year":"2020","unstructured":"Gammoh N (2020) The multifaceted functions of ATG16L1 in autophagy and related processes. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.249227","journal-title":"J Cell Sci"},{"key":"11195_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2024.101923","volume":"72","author":"A Severino","year":"2024","unstructured":"Severino A, Tohumcu E, Tamai L, Dargenio P, Porcari S, Rondinella D et al (2024) The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders. Best Pract Res Clin Gastroenterol 72:101923. https:\/\/doi.org\/10.1016\/j.bpg.2024.101923","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"11195_CR10","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L et al (2016) High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65(11):1812\u20131821. https:\/\/doi.org\/10.1136\/gutjnl-2015-309957","journal-title":"Gut"},{"issue":"3","key":"11195_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/ibd\/izab085","volume":"28","author":"A Mark-Christensen","year":"2022","unstructured":"Mark-Christensen A, Lange A, Erichsen R, Fr\u00f8slev T, Esen B, S\u00f8rensen HT et al (2022) Early-life exposure to antibiotics and risk for Crohn\u2019s disease: a nationwide Danish birth cohort study. Inflamm Bowel Dis 28(3):415\u2013422. https:\/\/doi.org\/10.1093\/ibd\/izab085","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"11195_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/2049-1891-4-27","volume":"4","author":"MR Ruth","year":"2013","unstructured":"Ruth MR, Field CJ (2013) The immune modifying effects of amino acids on gut-associated lymphoid tissue. J Anim Sci Biotechnol 4(1):27. https:\/\/doi.org\/10.1186\/2049-1891-4-27","journal-title":"J Anim Sci Biotechnol"},{"key":"11195_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goad068","volume":"11","author":"N Sharifinejad","year":"2023","unstructured":"Sharifinejad N, Mahmoudi E (2023) Dual function of fungi-derived cytokines in inflammatory bowel diseases: protection or inflammation. Gastroenterol Rep 11:goad068. https:\/\/doi.org\/10.1093\/gastro\/goad068","journal-title":"Gastroenterol Rep"},{"issue":"1","key":"11195_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgh.16795","volume":"40","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li X, Li J, Sun F, Duan L (2025) Gut microbiome-targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta-analysis. J Gastroenterol Hepatol 40(1):78\u201388. https:\/\/doi.org\/10.1111\/jgh.16795","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"11195_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00843-8","volume":"8","author":"F Liu","year":"2020","unstructured":"Liu F, Smith AD, Solano-Aguilar G, Wang TTY, Pham Q, Beshah E et al (2020) Mechanistic insights into the attenuation of intestinal inflammation and modulation of the gut microbiome by krill oil using in vitro and in vivo models. Microbiome 8(1):83. https:\/\/doi.org\/10.1186\/s40168-020-00843-8","journal-title":"Microbiome"},{"issue":"1","key":"11195_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C et al (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7(1):135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4","journal-title":"Signal Transduct Target Ther"},{"issue":"7285","key":"11195_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59\u201365. https:\/\/doi.org\/10.1038\/nature08821","journal-title":"Nature"},{"issue":"29","key":"11195_CR18","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar RD (2015) Role of the normal gut microbiota. World J Gastroenterol 21(29):8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11195_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ibd.21436","volume":"17","author":"S Mondot","year":"2011","unstructured":"Mondot S, Kang S, Furet JP, de Aguirre Carcer D, McSweeney C, Morrison M et al (2011) Highlighting new phylogenetic specificities of Crohn\u02bcs disease microbiota. Inflamm Bowel Dis 17(1):185\u2013192. https:\/\/doi.org\/10.1002\/ibd.21436","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"11195_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1756283x12454590","volume":"6","author":"J Bien","year":"2013","unstructured":"Bien J, Palagani V, Bozko P (2013) The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Ther Adv Gastroenterol 6(1):53\u201368. https:\/\/doi.org\/10.1177\/1756283x12454590","journal-title":"Ther Adv Gastroenterol"},{"issue":"9","key":"11195_CR21","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang M, Wang Y, Dorfman RG, Liu H, Yu T et al (2018) Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis 24(9):1926\u20131940. https:\/\/doi.org\/10.1093\/ibd\/izy182","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"11195_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1462-5822.2009.01381.x","volume":"12","author":"P Lapaquette","year":"2010","unstructured":"Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A (2010) Crohn\u2019s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 12(1):99\u2013113. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01381.x","journal-title":"Cell Microbiol"},{"issue":"1","key":"11195_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcmgh.2016.10.004","volume":"3","author":"A Shawki","year":"2017","unstructured":"Shawki A, McCole DF (2017) Mechanisms of intestinal epithelial barrier dysfunction by Adherent-Invasive Escherichia coli. Cell Mol Gastroenterol Hepatol 3(1):41\u201350. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.10.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"11195_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.594806","volume":"10","author":"W Su","year":"2020","unstructured":"Su W, Chen Y, Cao P, Chen Y, Guo Y, Wang S et al (2020) Fusobacterium nucleatum promotes the development of ulcerative colitis by inducing the autophagic cell death of intestinal epithelial. Front Cell Infect Microbiol 10:594806. https:\/\/doi.org\/10.3389\/fcimb.2020.594806","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11195_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-024-00651-7","volume":"16","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wang Y, Huang X, Yu X (2024) Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer. Gut Pathog 16(1):59. https:\/\/doi.org\/10.1186\/s13099-024-00651-7","journal-title":"Gut Pathog"},{"issue":"7902","key":"11195_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-022-04502-w","volume":"603","author":"XV Li","year":"2022","unstructured":"Li XV, Leonardi I, Putzel GG, Semon A, Fiers WD, Kusakabe T et al (2022) Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature 603(7902):672\u2013678. https:\/\/doi.org\/10.1038\/s41586-022-04502-w","journal-title":"Nature"},{"issue":"7","key":"11195_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.micres.2013.02.008","volume":"168","author":"L Yan","year":"2013","unstructured":"Yan L, Yang C, Tang J (2013) Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol Res 168(7):389\u2013395. https:\/\/doi.org\/10.1016\/j.micres.2013.02.008","journal-title":"Microbiol Res"},{"key":"11195_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo BM, Cintoni M, Porcari S, Rinninella E, Kaitsas F et al (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. https:\/\/doi.org\/10.3390\/nu15092211","journal-title":"Nutrients"},{"key":"11195_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu10020179","author":"E Herrmann","year":"2018","unstructured":"Herrmann E, Young W, Reichert-Grimm V, Weis S, Riedel CU, Rosendale D et al (2018) In vivo assessment of resistant starch degradation by the caecal microbiota of mice using RNA-based stable isotope probing-a proof-of-principle study. Nutrients. https:\/\/doi.org\/10.3390\/nu10020179","journal-title":"Nutrients"},{"key":"11195_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad039","author":"R Mart\u00edn","year":"2023","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Berm\u00fadez-Humar\u00e1n LG et al (2023) Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuad039","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"11195_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02995-4","volume":"7","author":"T Chen","year":"2017","unstructured":"Chen T, Long W, Zhang C, Liu S, Zhao L, Hamaker BR (2017) Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota. Sci Rep 7(1):2594. https:\/\/doi.org\/10.1038\/s41598-017-02995-4","journal-title":"Sci Rep"},{"issue":"2","key":"11195_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2291164","volume":"15","author":"SJ Gavzy","year":"2023","unstructured":"Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS (2023) Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes 15(2):2291164. https:\/\/doi.org\/10.1080\/19490976.2023.2291164","journal-title":"Gut Microbes"},{"issue":"1","key":"11195_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/mib.0000000000000590","volume":"22","author":"M Lopez-Siles","year":"2016","unstructured":"Lopez-Siles M, Martinez-Medina M, Sur\u00eds-Valls R, Aldeguer X, Sabat-Mir M, Duncan SH et al (2016) Changes in the abundance of Faecalibacterium prausnitzii phylogroups I and II in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer. Inflamm Bowel Dis 22(1):28\u201341. https:\/\/doi.org\/10.1097\/mib.0000000000000590","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"11195_CR34","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.3390\/cimb44070215","volume":"44","author":"T Grenda","year":"2022","unstructured":"Grenda T, Grenda A, Domaradzki P, Krawczyk P, Kwiatek K (2022) Probiotic potential of Clostridium spp.-advantages and doubts. Curr Issues Mol Biol 44(7):3118\u20133130. https:\/\/doi.org\/10.3390\/cimb44070215","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"11195_CR35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12864-018-5306-5","volume":"19","author":"AV Tyakht","year":"2018","unstructured":"Tyakht AV, Manolov AI, Kanygina AV, Ischenko DS, Kovarsky BA, Popenko AS et al (2018) Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn\u2019s disease discovered using metagenomic and genomic analyses. BMC Genom 19(1):968. https:\/\/doi.org\/10.1186\/s12864-018-5306-5","journal-title":"BMC Genom"},{"issue":"32","key":"11195_CR36","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.12998\/wjcc.v10.i32.11671","volume":"10","author":"L Zheng","year":"2022","unstructured":"Zheng L, Duan SL, Dai YC, Wu SC (2022) Role of adherent invasive Escherichia coli in pathogenesis of inflammatory bowel disease. World j clin cases 10(32):11671\u201311689. https:\/\/doi.org\/10.12998\/wjcc.v10.i32.11671","journal-title":"World j clin cases"},{"issue":"3","key":"11195_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jcmgh.2022.11.005","volume":"15","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Su X, Zhang C, Chen W, Wang Y, Yang X et al (2023) Klebsiella pneumoniae induces inflammatory bowel disease through caspase-11-mediated IL18 in the gut epithelial cells. Cell Mol Gastroenterol Hepatol 15(3):613\u2013632. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.11.005","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"11195_CR38","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","volume":"53","author":"F Rowan","year":"2010","unstructured":"Rowan F, Docherty NG, Murphy M, Murphy B, Calvin Coffey J, O\u2019Connell PR (2010) Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum 53(11):1530\u20131536. https:\/\/doi.org\/10.1007\/DCR.0b013e3181f1e620","journal-title":"Dis Colon Rectum"},{"key":"11195_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101656","author":"I Kushkevych","year":"2019","unstructured":"Kushkevych I, Le\u0161\u010danov\u00e1 O, Dordevi\u0107 D, Jan\u010d\u00edkov\u00e1 S, Ho\u0161ek J, V\u00edt\u011bzov\u00e1 M et al (2019) The sulfate-reducing microbial communities and meta-analysis of their occurrence during diseases of small-large intestine axis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8101656","journal-title":"J Clin Med"},{"issue":"1","key":"11195_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","volume":"166","author":"A Gilliland","year":"2024","unstructured":"Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA (2024) Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology 166(1):44\u201358. https:\/\/doi.org\/10.1053\/j.gastro.2023.09.019","journal-title":"Gastroenterology"},{"key":"11195_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040827","author":"CG Lee","year":"2022","unstructured":"Lee CG, Hwang S, Gwon SY, Park C, Jo M, Hong JE et al (2022) Bacteroides fragilis toxin induces intestinal epithelial cell secretion of interleukin-8 by the E-cadherin\/\u03b2-catenin\/NF-\u03baB dependent pathway. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10040827","journal-title":"Biomedicines"},{"issue":"1","key":"11195_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41385-020-0296-4","volume":"14","author":"A Iljazovic","year":"2021","unstructured":"Iljazovic A, Roy U, G\u00e1lvez EJC, Lesker TR, Zhao B, Gronow A et al (2021) Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation. Mucosal Immunol 14(1):113\u2013124. https:\/\/doi.org\/10.1038\/s41385-020-0296-4","journal-title":"Mucosal Immunol"},{"key":"11195_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2020.100008","volume":"3","author":"Z-Q Gu","year":"2020","unstructured":"Gu Z-Q, Tseng K-Y, Tsai Y-H (2020) Candida gut commensalism and inflammatory disease. Med Microecol 3:100008. https:\/\/doi.org\/10.1016\/j.medmic.2020.100008","journal-title":"Med Microecol"},{"issue":"3","key":"11195_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon JJ, Tang J, Li D, Wolf AJ, Michelsen KS, Funari V et al (2019) Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models. Cell Host Microbe 25(3):377\u201388.e6. https:\/\/doi.org\/10.1016\/j.chom.2019.01.007","journal-title":"Cell Host Microbe"},{"key":"11195_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf217","author":"JD F\u00fcchtbauer","year":"2025","unstructured":"F\u00fcchtbauer JD, Brovkina O, Sivickis K, Aalykke C, H\u00f8ivik ML, Andersen V et al (2025) Gut Mycobiome in inflammatory bowel disease: a systematic review of case-control studies. Inflamm Bowel Dis. https:\/\/doi.org\/10.1093\/ibd\/izaf217","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"11195_CR46","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v15.i2.92592","volume":"15","author":"HF Hetta","year":"2025","unstructured":"Hetta HF, Ahmed R, Ramadan YN, Fathy H, Khorshid M, Mabrouk MM et al (2025) Gut virome: new key players in the pathogenesis of inflammatory bowel disease. World J Methodol 15(2):92592. https:\/\/doi.org\/10.5662\/wjm.v15.i2.92592","journal-title":"World J Methodol"},{"issue":"1","key":"11195_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-021-01197-6","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Xu H, Xu J, Guo X, Zhao H, Chen Y et al (2021) F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis. AMB Express 11(1):33. https:\/\/doi.org\/10.1186\/s13568-021-01197-6","journal-title":"AMB Express"},{"issue":"5","key":"11195_CR48","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1042\/bst20210535","volume":"49","author":"X Luo","year":"2021","unstructured":"Luo X, Villablanca EJ (2021) Type 2 immunity in intestinal homeostasis and inflammatory bowel disease. Biochem Soc Trans 49(5):2371\u20132380. https:\/\/doi.org\/10.1042\/bst20210535","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"11195_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13492","volume":"231","author":"N Schlegel","year":"2021","unstructured":"Schlegel N, Boerner K, Waschke J (2021) Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-lessons from experimental models and patients. Acta Physiol (Oxf) 231(1):e13492. https:\/\/doi.org\/10.1111\/apha.13492","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"11195_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ecco-jcc\/jjac148","volume":"17","author":"K Saha","year":"2023","unstructured":"Saha K, Subramenium Ganapathy A, Wang A, Michael Morris N, Suchanec E, Ding W et al (2023) Autophagy reduces the degradation and promotes membrane localization of Occludin to enhance the intestinal epithelial tight junction barrier against paracellular macromolecule flux. J Crohns Colitis 17(3):433\u2013449. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac148","journal-title":"J Crohns Colitis"},{"issue":"7","key":"11195_CR51","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","volume":"178","author":"RM Al-Sadi","year":"2007","unstructured":"Al-Sadi RM, Ma TY (2007) IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Invest Med 178(7):4641\u20134649. https:\/\/doi.org\/10.4049\/jimmunol.178.7.4641","journal-title":"J Invest Med"},{"key":"11195_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010035","author":"G Dalmasso","year":"2019","unstructured":"Dalmasso G, Nguyen HTT, Fa\u00efs T, Massier S, Barnich N, Delmas J et al (2019) Crohn\u2019s disease-associated adherent-invasive Escherichia coli manipulate host autophagy by impairing SUMOylation. Cells. https:\/\/doi.org\/10.3390\/cells8010035","journal-title":"Cells"},{"key":"11195_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849985","volume":"10","author":"Q Ni","year":"2022","unstructured":"Ni Q, Zhang P, Li Q, Han Z (2022) Oxidative stress and gut microbiome in inflammatory skin diseases. Front Cell Dev Biol 10:849985. https:\/\/doi.org\/10.3389\/fcell.2022.849985","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"11195_CR54","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/mib.0000000000000238","volume":"21","author":"SS Cao","year":"2015","unstructured":"Cao SS (2015) Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease. Inflamm Bowel Dis 21(3):636\u2013644. https:\/\/doi.org\/10.1097\/mib.0000000000000238","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"11195_CR55","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1097\/mib.0000000000000117","volume":"20","author":"ME Johansson","year":"2014","unstructured":"Johansson ME (2014) Mucus layers in inflammatory bowel disease. Inflamm Bowel Dis 20(11):2124\u20132131. https:\/\/doi.org\/10.1097\/mib.0000000000000117","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"11195_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86907","volume":"1","author":"TC Liu","year":"2016","unstructured":"Liu TC, Gurram B, Baldridge MT, Head R, Lam V, Luo C et al (2016) Paneth cell defects in Crohn\u2019s disease patients promote dysbiosis. JCI Insight 1(8):e86907. https:\/\/doi.org\/10.1172\/jci.insight.86907","journal-title":"JCI Insight"},{"key":"11195_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02289-x","author":"A Mauduit","year":"2025","unstructured":"Mauduit A, Mas E, Sol\u00e0-Tapias N, M\u00e9nard S, Barreau F (2025) Main genetic factors associated with inflammatory bowel diseases and their consequences on intestinal permeability: involvement in gut inflammation. J Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-025-02289-x","journal-title":"J Gastroenterol"},{"issue":"1","key":"11195_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G (2017) Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279(1):70\u201389. https:\/\/doi.org\/10.1111\/imr.12567","journal-title":"Immunol Rev"},{"issue":"1","key":"11195_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-024-00321-w","volume":"44","author":"K Sugihara","year":"2024","unstructured":"Sugihara K, Kamada N (2024) Metabolic network of the gut microbiota in inflammatory bowel disease. Inflamm Regen 44(1):11. https:\/\/doi.org\/10.1186\/s41232-024-00321-w","journal-title":"Inflamm Regen"},{"issue":"2","key":"11195_CR60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/cmr.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240\u2013273. https:\/\/doi.org\/10.1128\/cmr.00046-08","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11195_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ecco-jcc\/jjac106","volume":"17","author":"T Secher","year":"2023","unstructured":"Secher T, Couturier A, Huot L, Bouscayrol H, Grandjean T, Boulard O et al (2023) A protective role of NOD2 on oxazolone-induced intestinal inflammation through IL-1\u03b2-mediated signalling pathway. J Crohns Colitis 17(1):111\u2013122. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac106","journal-title":"J Crohns Colitis"},{"issue":"2","key":"11195_CR62","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B et al (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129(2):550\u2013564. https:\/\/doi.org\/10.1016\/j.gastro.2005.05.002","journal-title":"Gastroenterology"},{"issue":"7","key":"11195_CR63","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3748\/wjg.v22.i7.2195","volume":"22","author":"A Yamada","year":"2016","unstructured":"Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N (2016) Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 22(7):2195\u20132205. https:\/\/doi.org\/10.3748\/wjg.v22.i7.2195","journal-title":"World J Gastroenterol"},{"issue":"9","key":"11195_CR64","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1128\/iai.69.9.5529-5537.2001","volume":"69","author":"AL Glasser","year":"2001","unstructured":"Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A (2001) Adherent invasive Escherichia coli strains from patients with Crohn\u2019s disease survive and replicate within macrophages without inducing host cell death. Infect Immun 69(9):5529\u20135537. https:\/\/doi.org\/10.1128\/iai.69.9.5529-5537.2001","journal-title":"Infect Immun"},{"key":"11195_CR65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/bs.apha.2024.10.002","volume":"101","author":"Y Li","year":"2024","unstructured":"Li Y, Huang M, Cardinale S, Su Y, Peters DE, Slusher BS et al (2024) Dectin-1 as a therapeutic target for inflammatory bowel disease. Adv pharmacol (San Diego, Calif) 101:237\u2013264. https:\/\/doi.org\/10.1016\/bs.apha.2024.10.002","journal-title":"Adv pharmacol (San Diego, Calif)"},{"key":"11195_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ani12020145","author":"M Giery\u0144ska","year":"2022","unstructured":"Giery\u0144ska M, Szulc-D\u0105browska L, Struzik J, Mielcarska MB, Gregorczyk-Zboroch KP (2022) Integrity of the intestinal barrier: the involvement of epithelial cells and microbiota-a mutual relationship. Animals. https:\/\/doi.org\/10.3390\/ani12020145","journal-title":"Animals"},{"issue":"3","key":"11195_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","volume":"28","author":"MM Thibaut","year":"2022","unstructured":"Thibaut MM, Bindels LB (2022) Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation. Trends Mol Med 28(3):223\u2013236. https:\/\/doi.org\/10.1016\/j.molmed.2021.12.006","journal-title":"Trends Mol Med"},{"key":"11195_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13080702","author":"W Li","year":"2024","unstructured":"Li W, Chen H, Tang J (2024) Interplay between bile acids and intestinal microbiota: regulatory mechanisms and therapeutic potential for infections. Pathogens. https:\/\/doi.org\/10.3390\/pathogens13080702","journal-title":"Pathogens"},{"key":"11195_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102337","volume":"66","author":"H Yang","year":"2023","unstructured":"Yang H, Huang Z, Li M, Zhang H, Fu L, Wang X et al (2023) Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-na\u00efve or anti-TNF-exposed Crohn\u2019s disease: a multicenter cohort study. eClin Med 66:102337. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102337","journal-title":"eClin Med"},{"issue":"9","key":"11195_CR70","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.12998\/wjcc.v10.i9.2660","volume":"10","author":"L Zheng","year":"2022","unstructured":"Zheng L, Wen XL, Duan SL (2022) Role of metabolites derived from gut microbiota in inflammatory bowel disease. World J Clin Cases 10(9):2660\u20132677. https:\/\/doi.org\/10.12998\/wjcc.v10.i9.2660","journal-title":"World J Clin Cases"},{"key":"11195_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biom15071017","author":"L Chulenbayeva","year":"2025","unstructured":"Chulenbayeva L, Jarmukhanov Z, Kaliyekova K, Kozhakhmetov S, Kushugulova A (2025) Quantitative alterations in short-chain fatty acids in inflammatory bowel disease: a systematic review and meta-analysis. Biomolecules. https:\/\/doi.org\/10.3390\/biom15071017","journal-title":"Biomolecules"},{"issue":"1","key":"11195_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02448-w","volume":"23","author":"Y-y Fan","year":"2025","unstructured":"Fan Y-y, Yang Z-j, Wang M-y, Qin S-m, Lei J-q, Xie Q-l et al (2025) Resveratrol alleviates IBD-associated neuropsychiatric comorbidities via microbiota-dependent arginine metabolism reprogramming and microglial M2 polarization through gut-brain axis. Cell Commun Signal 23(1):429. https:\/\/doi.org\/10.1186\/s12964-025-02448-w","journal-title":"Cell Commun Signal"},{"issue":"9","key":"11195_CR73","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139(9):1619\u20131625. https:\/\/doi.org\/10.3945\/jn.109.104638","journal-title":"J Nutr"},{"key":"11195_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1291724","volume":"14","author":"K Prame Kumar","year":"2023","unstructured":"Prame Kumar K, Ooi JD, Goldberg R (2023) The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease. Front Microbiol 14:1291724. https:\/\/doi.org\/10.3389\/fmicb.2023.1291724","journal-title":"Front Microbiol"},{"key":"11195_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102340","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gan H, Duan X, Li G (2024) Targeting the intestinal microbiota: a novel direction in the treatment of inflammatory bowel disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12102340","journal-title":"Biomedicines"},{"issue":"1","key":"11195_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05122-w","volume":"22","author":"H Zhao","year":"2024","unstructured":"Zhao H, Zhou Y, Xu J, Zhang Y, Wang H, Zhao C et al (2024) Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK\/STAT3\/FOXO3 axis inactivation. J Transl Med 22(1):369. https:\/\/doi.org\/10.1186\/s12967-024-05122-w","journal-title":"J Transl Med"},{"issue":"Suppl 1","key":"11195_CR77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jcag\/gwz047.041","volume":"3","author":"L Rondeau","year":"2020","unstructured":"Rondeau L, Clarizio AV, Jury J, Gibson DL, Bercik P, Sokol H et al (2020) A42 microbial metabolism of dietary tryptophan enhances aryl hydrocarbon receptor activation: implications for IBD. J Can Assoc Gastroenterol 3(Suppl 1):50\u201351. https:\/\/doi.org\/10.1093\/jcag\/gwz047.041","journal-title":"J Can Assoc Gastroenterol"},{"key":"11195_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1279172","volume":"13","author":"JJ Hou","year":"2023","unstructured":"Hou JJ, Ma AH, Qin YH (2023) Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota. Front Cell Infect Microbiol 13:1279172. https:\/\/doi.org\/10.3389\/fcimb.2023.1279172","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"11195_CR79","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","volume":"183","author":"P Vavassori","year":"2009","unstructured":"Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S (2009) The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 183(10):6251\u20136261. https:\/\/doi.org\/10.4049\/jimmunol.0803978","journal-title":"J Immunol"},{"key":"11195_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121570","author":"MN Rossi","year":"2024","unstructured":"Rossi MN, Cervelli M (2024) Polyamine metabolism and functions: key roles in cellular health and disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom14121570","journal-title":"Biomolecules"},{"issue":"6","key":"11195_CR81","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1134\/S0026893323060043","volume":"57","author":"DA Chernyavskij","year":"2023","unstructured":"Chernyavskij DA, Galkin II, Pavlyuchenkova AN, Fedorov AV, Chelombitko MA (2023) Role of mitochondria in intestinal epithelial barrier dysfunction in inflammatory bowel disease. Mol Biol 57(6):1028\u20131042","journal-title":"Mol Biol"},{"issue":"1","key":"11195_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-022-00499-9","volume":"14","author":"X Xu","year":"2022","unstructured":"Xu X, Ocansey DKW, Hang S, Wang B, Amoah S, Yi C et al (2022) The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease. Gut Pathog 14(1):26. https:\/\/doi.org\/10.1186\/s13099-022-00499-9","journal-title":"Gut Pathog"},{"issue":"2","key":"11195_CR83","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P et al (2019) Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 321(2):156\u2013164. https:\/\/doi.org\/10.1001\/jama.2018.20046","journal-title":"JAMA"},{"issue":"2","key":"11195_CR84","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/nutrit\/nuae022","volume":"83","author":"M Xu","year":"2025","unstructured":"Xu M, Zhang W, Lin B, Lei Y, Zhang Y, Zhang Y et al (2025) Efficacy of probiotic supplementation and impact on fecal microbiota in patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 83(2):e65\u2013e73. https:\/\/doi.org\/10.1093\/nutrit\/nuae022","journal-title":"Nutr Rev"},{"issue":"8","key":"11195_CR85","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","volume":"8","author":"FS Cheng","year":"2020","unstructured":"Cheng FS, Pan D, Chang B, Jiang M, Sang LX (2020) Probiotic mixture VSL#3: an overview of basic and clinical studies in chronic diseases. World J Clin Cases 8(8):1361\u20131384. https:\/\/doi.org\/10.12998\/wjcc.v8.i8.1361","journal-title":"World J Clin Cases"},{"issue":"1","key":"11195_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-025-01002-2","volume":"22","author":"W Liu","year":"2025","unstructured":"Liu W, Zhang S, Dong C, Lv X, Zheng X, Zhao W et al (2025) Probiotics and inflammatory bowel disease: an umbrella meta-analysis of relapse, recurrence, and remission outcomes. Nutr Metab 22(1):111. https:\/\/doi.org\/10.1186\/s12986-025-01002-2","journal-title":"Nutr Metab"},{"key":"11195_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03043-w","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhao L, Liang A, Geng X, Hou M, Cheng H et al (2024) Resistant starch grafted cerium-sulfasalazine infinite coordination polymers synergistically remold intestinal metabolic microenvironment for inflammatory bowel disease therapy. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-024-03043-w","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"11195_CR88","first-page":"14","volume":"18","author":"R Sedano","year":"2022","unstructured":"Sedano R, Ma C, Jairath V, Feagan BG (2022) Janus kinase inhibitors for the management of patients with inflammatory bowel disease. Gastroenterol Hepatol 18(1):14\u201327","journal-title":"Gastroenterol Hepatol"},{"issue":"14","key":"11195_CR89","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","volume":"385","author":"WJ Sandborn","year":"2021","unstructured":"Sandborn WJ, Feagan BG, D\u2019Haens G, Wolf DC, Jovanovic I, Hanauer SB et al (2021) Ozanimod as induction and maintenance therapy for ulcerative colitis. N Engl J Med 385(14):1280\u20131291. https:\/\/doi.org\/10.1056\/NEJMoa2033617","journal-title":"N Engl J Med"},{"issue":"3","key":"11195_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167648","volume":"1871","author":"J-C Xue","year":"2025","unstructured":"Xue J-C, Hou X-T, Zhao Y-W, Yuan S (2025) Biological agents as attractive targets for inflammatory bowel disease therapeutics. Biochimica et Biophysica Acta (BBA) 1871(3):167648. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167648","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"11195_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03331-6","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Jiang HY, Zhang YX, Jin HY, Fei BY, Jiang JL (2023) Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther 14(1):103. https:\/\/doi.org\/10.1186\/s13287-023-03331-6","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"11195_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00802-1","volume":"13","author":"G Serrano-G\u00f3mez","year":"2025","unstructured":"Serrano-G\u00f3mez G, Ya\u00f1ez F, Soler Z, Pons-Tarin M, Mayorga L, Herrera-deGuise C et al (2025) Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology. Biomark Res 13(1):85. https:\/\/doi.org\/10.1186\/s40364-025-00802-1","journal-title":"Biomark Res"},{"key":"11195_CR93","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241272001","volume":"17","author":"C Kulkarni","year":"2024","unstructured":"Kulkarni C, Liu D, Fardeen T, Dickson ER, Jang H, Sinha SR et al (2024) Artificial intelligence and machine learning technologies in ulcerative colitis. Ther Adv Gastroenterol 17:17562848241272000. https:\/\/doi.org\/10.1177\/17562848241272001","journal-title":"Ther Adv Gastroenterol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11195-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11195-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11195-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:07:15Z","timestamp":1762351635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11195-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11195"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11195-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"47"}}